A study has shown that CRISPR can be used as a regenerative technique to treat Duchenne muscular dystrophy, which could be developed as a therapeutic option for humans.
List view / Grid view
Filter the results
Genomics is the branch of molecular biology concerned with the structure, function, evolution, and mapping of genomes.
CRISPR is the buzzword of the moment in the drug discovery industry – mainly due to its potential to correct disease-causing mutations. However, those using the technology need to be mindful that it is used responsibly, and possible risks are considered before use. Mark Behlke discusses the potential of CRISPR…
Chronic inflammatory processes in ageing brains lead to lymphoma cells that have entered the brain tissue being retained.
We are on the precipice of realising the true potential of genomics studies. Following completion of the Human Genome Project six years ago, huge strides have been made in understanding how the genome works, shedding light on disease pathogenesis and forging therapeutic efforts. In this article, Pushpanathan Muthuirulan explains how…
Researchers have discovered a particular protein that is required for enterovirus replication and survival, presenting a therapeutic target.
Over three decades, Bio-Rad has built a broad genomics portfolio that touches on nearly every area of life science.
A team has used a lentiviral capsid-based bionanoparticle system to deliver CRISPR-Cas9 gene editing therapies, reducing undesired effects.
Researchers have developed a new treatment method which turned glial cells into functioning neurons in mice after stroke.
A ground-breaking nervous system discovery could be significant for the treatment of different neurological diseases.
This issue includes an investigation into utilising recombinant antibodies for research, a highlight on protein design using computational methods and an examination of the advances in genomic medicine. Also in the issue are articles on next generation sequencing and upstream bioprocessing.
The UK Brain Banks Network has been enhanced to include genomic data, which can be accessed by researchers worldwide.
A protein that causes pancreatic ductal adenocarcinoma has been identified as a therapeutic target by researchers.